Innovator’s Pitch Challenge

Interested in Connecting? Please contact:
Carlos Castro-Gonzalez
Co-Founder & CEO 

Message the company or request a 1:1 meeting here

Company Description

Leuko is an MIT spinout developing PointCheckTM, the world’s first medical device that can monitor white blood cells non-invasively. By enabling more frequent at-home monitoring, Leuko aims to improve clinical outcomes for more than 2M cancer chemotherapy patients a year, reduce their chemotherapy-related hospital readmissions by 50% and save >$6B annually in healthcare cost.

Pitch Deck

Executive Summary